Clinical Trials Directory

Trials / Completed

CompletedNCT06908967

A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions

An Open-label, Single-blinded, Randomized, 2-way Crossover, Performance Study of the EyeMirage (Test Device) Relative to Standard of Care (Reference Device) in Patients Undergoing Standard Eye Examinations for Various Conditions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Neuroptek Corporation Inc. · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four eye tests that are done through the current standard used in eye clinics and that of this new device. Participants of this study will undergo the four eye tests using both the new device and the standard of care devices. The study will be done in one visit to the eye clinic. Thirty days after the eye tests were done, participants will be called by the clinic for a general follow-up and to discuss any problems, if needed.

Conditions

Interventions

TypeNameDescription
DEVICEEyeMirage deviceThis is a novel, smartphone-based device powered by artificial intelligence that will be used for virtual and remote routine eye examinations.

Timeline

Start date
2025-06-13
Primary completion
2026-02-24
Completion
2026-02-24
First posted
2025-04-03
Last updated
2026-03-12

Locations

4 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06908967. Inclusion in this directory is not an endorsement.